RAM
SGMT icon

Riggs Asset Management’s Sagimet Biosciences SGMT Stock Holding History

Riggs Asset Management’s Portfolio SGMT Stock Details SGMT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-1,025
Closed -$7.81K – 725
2025
Q2 		$7.81K Hold
1,025
– – ﹤0.01% 373
2025
Q1 		$3.34K Hold
1,025
– – ﹤0.01% 354
2024
Q4 		$4.84K Hold
1,025
– – ﹤0.01% 300
2024
Q3 		$2.84K Buy
1,025
+25
+3% +$77 ﹤0.01% 339
2024
Q2 		$3.42K Buy
+1,000
New +$4.59K ﹤0.01% 328

Other funds holding SGMT

WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
BOCH
Blue Owl Capital Holdings New York $372M AUM 78.25% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SSA
Schonfeld Strategic Advisors New York $14.2B AUM 37.17% 1-Year Est. Return

Riggs Asset Management's SGMT Position: Q3 2025 in Review

Riggs Asset Management sold out of Sagimet Biosciences (SGMT) in Q3 2025, closing a stake of 1,025 shares — an estimated $7.81K sold.

Riggs Asset Management first reported a position in SGMT in Q2 2024 and held it in 5 quarters. The position peaked at $7.81K in Q2 2025. 72 funds tracked by Wall St. Rank hold SGMT as of Q3 2025.

  • Riggs Asset Management reported no remaining Sagimet Biosciences position as of Q3 2025 after selling out during the quarter.
  • Riggs Asset Management sold 1,025 Sagimet Biosciences shares in Q3 2025, an estimated $7.81K.
  • Riggs Asset Management first reported a position in Sagimet Biosciences in Q2 2024 and held it in 5 quarters.
  • Riggs Asset Management's Sagimet Biosciences position peaked at $7.81K in Q2 2025.
  • 72 funds tracked by Wall St. Rank held Sagimet Biosciences as of Q3 2025.

Based on Riggs Asset Management's 13F filing for Q3 2025, filed 13 Nov 2025.